Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M696Revenue (TTM) $M7.2Net Margin (%)-2,257.6Altman Z-Score-8.5
Enterprise Value $M601EPS (TTM) $-1.3Operating Margin %-2,259.4Piotroski F-Score4
P/E(ttm)--Beneish M-Score-5.1Pre-tax Margin (%)-2,257.6Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %-8.7Quick Ratio7.4Cash flow > EarningsY
Price/Sales97.35-y EBITDA Growth Rate %1.8Current Ratio7.4Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-113.8Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-573.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M132ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ZIOP

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ZIOPJoel Greenblatt 2016-09-30 Sold Out $4.49 - $6.04
($5.36)
$ 5.788%Sold Out0
ZIOPJoel Greenblatt 2016-06-30 Reduce-0.01%$5.31 - $8.92
($7.26)
$ 5.78-20%Reduce -55.68%42,723
ZIOPJoel Greenblatt 2016-03-31 Reduce$4.89 - $9.59
($6.81)
$ 5.78-15%Reduce -12.49%96,406
ZIOPJoel Greenblatt 2015-12-31 Buy 0.01%$8.07 - $14.57
($11.04)
$ 5.78-48%New holding110,163
ZIOPJoel Greenblatt 2015-06-30 Sold Out -0.01%$8.81 - $12.5
($10.36)
$ 5.78-44%Sold Out0
ZIOPJoel Greenblatt 2015-03-31 Buy 0.01%$4.96 - $14
($9.88)
$ 5.78-41%New holding109,080
ZIOPFirst Eagle Investment 2013-06-30 Sold Out -0.0012%$1.52 - $2.62
($1.86)
$ 5.78211%Sold Out0
ZIOPFirst Eagle Investment 2013-03-31 Buy $1.72 - $5.71
($4.42)
$ 5.7831%New holding200,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ZIOP is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ZIOP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BELBEL CAESAR JCOO, CLO, and Secretary 2015-11-19Sell153,333$12.84-54.98view
LEBEL FRANCOISExecutive Vice President R&D 2015-06-09Sell50,000$10.12-42.89view
BRENNAN MURRAYDirector 2015-06-04Sell40,000$9.7-40.41view
Lafond Kevin GVice Pres., Treasurer, & CAO 2015-06-03Sell57,500$9.65-40.1view
KIRK RANDAL JDirector, 10% Owner 2015-02-09Buy1,440,000$8.75-33.94view
KIRK RANDAL JDirector, 10% Owner 2013-10-29Buy2,857,143$3.565.14view
KIRK RANDAL JDirector, 10% Owner 2012-01-20Buy1,923,075$5.211.15view
KIRK RANDAL JDirector, 10% Owner 2011-08-23Buy38,294$4.9915.83view
KIRK RANDAL JDirector, 10% Owner 2011-08-22Buy461,646$4.9217.48view
Fowler WycheDirector 2011-08-10Buy5,000$5.1911.37view

Quarterly/Annual Reports about ZIOP:

News about ZIOP:

Articles On GuruFocus.com
Intrexon Corp is expanding his business Jun 25 2015 
Hayman Advisors Update - Second Quarter Sells and Company Results Aug 26 2013 
Bass’ New Buy – ZIOPHARM Oncology Inc. May 16 2013 
The Far-Off Four, 52-week Lows Held by Gurus May 11 2013 

More From Other Websites
ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Jan 11 2017
ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Jan 10 2017
ZIOPHARM and Intrexon Announce Cooperative Research and Development Agreement with the National... Jan 10 2017
Exclusive: Ziopharm CEO Talks Partnerships, Balance Sheet And JPM Healthcare Conference Presentation Jan 09 2017
ZIOPHARM to Present at the 35th Annual J.P. Morgan Healthcare Conference Jan 04 2017
Implied Volatility Surging for ZIOPHARM Oncology (ZIOP) Stock Options Jan 03 2017
ZIOPHARM Oncology, Inc. – Value Analysis (NASDAQ:ZIOP) : December 23, 2016 Dec 23 2016
ETFs with exposure to ZIOPHARM Oncology, Inc. : December 22, 2016 Dec 22 2016
ZIOPHARM Oncology, Inc. breached its 50 day moving average in a Bearish Manner : ZIOP-US : December... Dec 22 2016
Should You Avoid ZIOPHARM Oncology Inc. (ZIOP)? Dec 18 2016
Are Options Traders Betting on a Big Move in ZIOPHARM Oncology (ZIOP) Stock? Dec 13 2016
Hedge Funds Continue to Hold On To Quality Systems, Inc. (QSII) Dec 05 2016
ETFs with exposure to ZIOPHARM Oncology, Inc. : December 5, 2016 Dec 05 2016
5 Stocks Hedge Funds Hate The Most Nov 26 2016
ETFs with exposure to ZIOPHARM Oncology, Inc. : November 23, 2016 Nov 23 2016
Put sellers see floor in Ziopharm Nov 21 2016
ZIOPHARM Oncology, Inc. :ZIOP-US: Earnings Analysis: Q3, 2016 By the Numbers : November 18, 2016 Nov 18 2016
ZIOPHARM ONCOLOGY INC Financials Nov 17 2016
ZIOPHARM Announces Clinical Data On Brain Cancer Drug Nov 17 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)